Liquids Research Limited (LRL), founded in 1990 by Professor K. O’Grady and Dr S. W. Charles, is a leading manufacturer of ferrofluids (magnetic fluids) occupying modern facilities in Bangor, North Wales.

The founders are internationally recognised as experts in the field of bio separation, magnetic liquids, ferrofluids, fluids and lead many research projects covering the fundamental aspects of these materials and other fields also based on fine magnetic particles.

The company is continuously updated on the latest research and development and thus are an obvious choice for consultancy advice in these fields. The founders belong to several committees involved with magnetic liquids and are the authors of many original scientific papers.

Ferrofluids and other magnetic composite materials are produced in the company’s well equipped laboratories augmented by access to additional research facilities through world class partners. The strong research and development base enables a fast response in the development of new specialist materials and products required to meet new technological demands.

Magnetic nanoparticles for bio applications are becoming increasingly important in the field of assays. More recently there has been significant interest in the use of magnetic nanoparticles for lysosome separation work, principally due to the work of Dr. Emyr Lloyd Evans and his research group at the University of Cardiff, using specialist dispersions of magnetic nanoparticles called DexoMAG® developed and manufactured by Liquids Research. The harvesting of healthy lysosomes is crucial for the study of lysosomal storage diseases, which are the most common form of childhood neurodegeneration. DexoMAG® has proved to be particularly effective in harvesting lysosomes through magnetic separation. The company also provides fluorescent dextran coated nanoparticles called FluoreMAG® which comes as both FITC and TRIC types.

The use of magnetic nanoparticles for hyperthermic heating applications is of growing interest in the treatment of tumours. Liquids Research have developed a range of magnetic nanoparticle dispersions called HyperMAG®. Animal studies have shown reductions in the size of breast cancer (MDA-MB-231) tumours by 85% (S. Kossatz et al, Pharm. Res., 2014, 11095-014-1417-0). We are now looking to exploit HyperMAG® with international partners who wish to utilise hyperthermia as a clinical procedure.

More recently LRL has developed their own range of magnetic polymer beads called SphereMAG® which LRL are making available through their website.

Where magnetic nanoparticle design is the solution, Liquids Research welcome collaborations with other companies and research laboratories. With over 30 years of bespoke magnetic nanoparticle development and production, Liquids Research is the right partner for you.